Works matching IS 1082801X AND DT 2007 AND VI 42 AND IP 8
Results: 54
FDA advisory panel votes to keep rosiglitazone on market, but not without caveats.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Debate about rosiglitazone safety prompts hearing in House; FDA seeks to update clinical research policies.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Nebivolol demonstrates neutral effect on glucose levels.
- Published in:
- 2007
- Publication type:
- Journal Article
Sumatriptan plus naproxen reduces traditional and nontraditional migraine symptoms.
- Published in:
- 2007
- Publication type:
- Journal Article
Pulmonary effects of inhaled insulin are small, reversible.
- Published in:
- 2007
- Publication type:
- Journal Article
Exenatide associated with sustained blood glucose control, weight loss after 3 years of treatment.
- Published in:
- 2007
- Publication type:
- Journal Article
Quick-release bromocriptine has favorable cardiovascular safety profile [corrected] [published erratum appears in FORMULARY 2007 Oct;42(10):501].
- Published in:
- 2007
- Publication type:
- Journal Article
Lipid-lowering therapies reduce development of peripheral neuropathy.
- Published in:
- 2007
- Publication type:
- Journal Article
PROactive: pioglitazone improves CV outcomes in patients with renal dysfunction, type 2 diabetes, and macrovascular disease.
- Published in:
- 2007
- Publication type:
- Journal Article
Researchers debate the CV safety of rosiglitazone.
- Published in:
- 2007
- Publication type:
- Journal Article
SOLAR: initial rosuvastatin superior to atorvastatin, simvastatin for reaching LDL-C goals in high-risk patients.
- Published in:
- 2007
- Publication type:
- Journal Article
Patients with cancer and ACS, with or without thrombocytopenia, may benefit from use of aspirin.
- Published in:
- 2007
- Publication type:
- Journal Article
Lamotrigine, valproate emerge as superior epilepsy treatment options as assessed in SANAD trial.
- Published in:
- 2007
- Publication type:
- Journal Article
Bare-metal and drug-eluting stents yield similar cardiac event risks, according to pooled analysis.
- Published in:
- 2007
- Publication type:
- Journal Article
LOCSS trial: once-daily fluticasone plus salmeterol superior to montelukast as step-down therapy for mild persistent asthma.
- Published in:
- 2007
- Publication type:
- Journal Article
Budesonide plus formoterol associated with better control of persistent asthma control than gold standard therapy.
- Published in:
- 2007
- Publication type:
- Journal Article
HORIZON: yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis.
- Published in:
- 2007
- Publication type:
- Journal Article
ADAPT: Naproxen and celecoxib demonstrated to be ineffective In primary prevention of AD.
- Published in:
- 2007
- Publication type:
- Journal Article
Drug and formulary trends.
- Published in:
- 2007
- Publication type:
- Journal Article
Vernakalant.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
Dr von Eschenbach's vision: FDA's newest commissioner faces multiple challenges.
- Published in:
- 2007
- By:
- Publication type:
- Journal Article
DAD study: use of protease inhibitors increases risk of myocardial infarction.
- Published in:
- 2007
- Publication type:
- Journal Article
Interim analysis of RECORD trial provides inconclusive data regarding cardiovascular safety of rosiglitazone.
- Published in:
- 2007
- Publication type:
- Journal Article
Acute pain and migraine/headache.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 512
- Publication type:
- Article
FDA advisory panel votes to keep rosiglitazone on market, but not without caveats.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 510
- By:
- Publication type:
- Article
Debate about rosiglitazone safety prompts hearing in House; FDA seeks to update clinical research policies.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 505
- Publication type:
- Article
Sumatriptan plus naproxen reduces traditional and nontraditional migraine symptoms.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 504
- Publication type:
- Article
Nebivolol demonstrates neutral effect on glucose levels.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 504
- Publication type:
- Article
Exenatide associated with sustained blood glucose control, weight loss after 3 years of treatment.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 503
- Publication type:
- Article
Pulmonary effects of inhaled insulin are small, reversible.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 502
- Publication type:
- Article
Quick-release bromocriptine has favorable cardiovascular safety profile.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 501
- Publication type:
- Article
Lipid-lowering therapies reduce development of peripheral neuropathy.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 498
- Publication type:
- Article
PROactive: Pioglitazone improves CV outcomes in patients with renal dysfunction, type 2 diabetes, and macrovascular disease.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 497
- Publication type:
- Article
Researchers debate the CV safety of rosiglitazone.
- Published in:
- 2007
- Publication type:
- Proceeding
SOLAR: Initial rosuvastatin superior to atorvastatin, simvastatin for reaching LDL-C goals in high-risk patients.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 496
- Publication type:
- Article
Patients with cancer and ACS, with or without thrombocytopenia, may benefit from use of aspirin.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 494
- Publication type:
- Article
Lamotrigine, vaiproate emerge as superior epilepsy treatment options as assessed in SANAD trial.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 494
- Publication type:
- Article
Bare-metal and drug-eluting stents yield similar cardiac event risks, according to pooled analysis.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 493
- Publication type:
- Article
LOCSS trial: Once-daily fluticasone plus salmeterol superior to montelukast as step-down therapy for mild persistent asthma.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 490
- Publication type:
- Article
Budesonide plus formoterol associated with better control of persistent asthma control than gold standard therapy.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 490
- Publication type:
- Article
ADAPT: Naproxen and celecoxib demonstrated to be ineffective In primary prevention of AD.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 488
- Publication type:
- Article
HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 488
- Publication type:
- Article
Vernakalant.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 475
- By:
- Publication type:
- Article
Drug and Formulary Trends.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 472
- Publication type:
- Article
Dr von Eschenbach's vision: FDA's newest commissioner faces multiple challenges.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 467
- By:
- Publication type:
- Article
Safety labeling updates & new warnings.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 466
- Publication type:
- Article
DAD study: Use of protease inhibitors increases risk of myocardial infarction.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 465
- Publication type:
- Article
Interim analysis of RECORD trial provides inconclusive data regarding cardiovascular safety of rosiglitazone.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 465
- Publication type:
- Article
FDA actions in brief.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 464
- Publication type:
- Article
First-time generic approvals.
- Published in:
- Formulary, 2007, v. 42, n. 8, p. 463
- Publication type:
- Article